Asia
Harbin Pharmaceutical Gets Marketing Approval for Potassium Sulfate API
Harbin Pharmaceutical (SHA:600664) obtained marketing approval from China's drug regulator for its potassium sulfate active pharmaceutical ingredient.Potassium Sulfate is one of the active pharmaceutical ingredients in Sodium Sulfate, Magnesium Sulfate, and Potassium Sulfate Oral Concentrated Solution, exerting an osmotic laxative effectShares of the pharmaceutical company rose nearly 2% in recent trade.
SHA:600664
